LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer

C. Saura Manich, Joyce O’Shaughnessy, Philippe Aftimos, Evelyn van den Tweel, M. Oesterholt, Santiago Escrivá-de-Romaní, N. Quenel Tueux, T.J.Y. Tan, Joline S.J. Lim, Sylvain Ladoire, Anne Armstrong, Tim Crook, Agostina Stradella, Giulia Bianchi, Renée L. Mulder, N.P. Koper, Nicholas C. Turner